top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Psilocybin for Anorexia Nervosa
In this webinar, Dr Meg Spriggs explains the potential of psilocybin to treat anorexia nervosa, and offers valuable insights from the...
Drug Science
Apr 22, 20211 min read
Psilocybin Therapy for Depression - Clinical Insights
After the release of the first comparison of psilocybin with an SSRI antidepressant, Michelle Baker Jones & Leonie Schneider explain what...
Drug Science
Apr 19, 20211 min read
Women in Psychedelic Science - Part 3
The Contradictions of Ketamine: results from a new clinical trial treating alcohol use disorder – Prof Celia Morgan Celia Morgan is a...
Drug Science
Mar 29, 20212 min read
Psilocybin Treatment for Depression - Clinical Insights
Psilocybin for depression is one of the most promising applications of psychedelic therapy. In particular, psilocybin therapy is being...
Drug Science
Mar 11, 20211 min read
Psilocybin Treatment for Depression - Patient Perspective
Clinical trials are currently investigating psilocybin therapy, as a treatment for depression at research centres around the world. This...
Drug Science
Mar 4, 20212 min read
Psychedelic Microdosing - Just a Placebo Effect?
Authors: Balázs Szigeti, Laura Kartner, Allan Blemings, Fernando Rosas, Amanda Feilding, David J. Nutt, Robin L. Carhart-Harris, David...
Balázs Szigeti, Professor David Nutt and more
Mar 2, 20212 min read
2020 - The Year Of The Mushroom
By Dr Hannah Thurgur an Honorary Research Assistant for Drug Science As we welcome in the new year, Drug Science reflects on the year of...
Dr Hannah Thurgur
Feb 1, 20218 min read
Women in Psychedelic Science - Part 2
This is the second Women in Psychedelic Science symposium to showcase the ground-breaking and outstanding work of women in psychedelics....
Drug Science
Jan 22, 20211 min read
Study Drug Sessions - Insights on psychedelic microdosing
Laura Kaertner – Insights on psychedelic microdosing Laura Kaertner is a research assistant at the Centre of Psychedelic Research at...
Drug Science
Jan 14, 20212 min read
Clinical Insights - MDMA for Alcohol Use Disorder
Dr Ben Sessa – MDMA for Alcohol Use Disorder Dr Ben Sessa presents the first data from the open-label safety and tolerability proof of...
Drug Science
Dec 3, 20202 min read
2019: A year of expansion in psychedelic research, industry, and deregulation
Authors: Jacob S Aday, Emily K Bloesch, Christopher C Davoli Published: November 25, 2020 Public and scientific interest into psychedelic...
Jacob S Aday, Emily K Bloesch and more
Nov 26, 20202 min read
Sex, sexuality and body image - Study Drug Sessions
Dr Bruna Giribaldi – Sex, sexuality and body image Dr Bruna Giribaldi is a pharmacologist and has been a part of the Centre for...
Drug Science
Nov 19, 20202 min read
Clinical Insights - Psilocybin for Anorexia Nervosa
Dr Meg Spriggs is a researcher at the Centre for Psychedelic Research at Imperial College London where she works as a trial-coordinator and
Meg Spriggs
Nov 5, 20202 min read
Improved colour blindness symptoms associated with recreational psychedelic use
Authors: JEC Anthony, A Winstock, JA Ferris, DJ Nutt Published: November 2, 2020 It is well documented that psychedelic drugs can have a...
JEC Anthony, A Winstock and more
Nov 4, 20202 min read
Women in Psychedelic Science
On October 13th 2020, the MPWG hosted its first symposium entitled ‘Women in Psychedelic Science’, showcasing the ground-breaking and...
Drug Science
Oct 16, 20201 min read
Medical Psilocybin Educational Resources
The psychotropic effects of Psilocybe mushrooms were largely unknown in the West until the 1950s, despite evidence that they had a long...
Drug Science
Jul 14, 20202 min read
Launch of the Medical Psychedelics Working Group
On Tuesday July 14th, 2020, Drug Science will launch a new working group of experts, policy makers and scientists. Its primary role is to...
James Bunn
Jun 19, 20202 min read
Law on psychedelic drugs blocks vital medical research
Professor David Nutt’s recent comment in ‘The Times‘ addresses how the ‘Law on psychedelic drugs blocks vital medical research‘. In the...
Drug Science
Dec 11, 20192 min read
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future
This special issue of the Journal of Psychopharmacology contains two landmark studies – the most rigorous controlled trials to date using...
Drug Science
Dec 10, 20164 min read
bottom of page